Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Martin

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Cancer Research|July 20, 2007
Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic doseKaren Brown, Elaine M Tompkins, David J Boocock, et al.
Translational Vision Science & Technology|January 15, 2024
Capabilities and Limitations of Student-Led Free Vision Screening Programs in the United StatesNirupama Devanathan, Melanie Scheive, Baraa S Nawash, et al.
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approachesThomas H Broschard, Susanne Glowienke, Uma S Bruen, et al.
Science Translational Medicine|December 1, 2012
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophyElizabeth A Martin, Rita Barresi, Barry J Byrne, et al.
Cancer Research|December 18, 2003
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometryElizabeth A Martin, Karen Brown, Margaret Gaskell, et al.
Psychiatric Services (Washington, D.C.)|January 30, 2026
Social Determinants and Mental Health Care Utilization Among Individuals at Clinical High Risk for PsychosisEmily Petti, Miranda A Bridgwater, Madeline E Snyder, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approachesJessica C Graham, Mark W Powley, Erika Udovic, et al.
Critical Reviews in Toxicology|June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticalsPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Schizophrenia Research|February 27, 2022
Internalized stigma mediates the relation between psychosis-risk symptoms and subjective quality of life in a help-seeking sampleLeeAnn Akouri-Shan, Joseph S DeLuca, Steven C Pitts, et al.
Frontiers in Psychiatry|March 30, 2023
Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United StatesMiranda A Bridgwater, Emily Petti, Maksim Giljen, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Cancer Research|July 20, 2007
Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic doseKaren Brown, Elaine M Tompkins, David J Boocock, et al.
Translational Vision Science & Technology|January 15, 2024
Capabilities and Limitations of Student-Led Free Vision Screening Programs in the United StatesNirupama Devanathan, Melanie Scheive, Baraa S Nawash, et al.
Regulatory Toxicology and Pharmacology : RTP|August 30, 2016
Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - Current challenges and approachesThomas H Broschard, Susanne Glowienke, Uma S Bruen, et al.
Science Translational Medicine|December 1, 2012
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophyElizabeth A Martin, Rita Barresi, Barry J Byrne, et al.
Cancer Research|December 18, 2003
Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometryElizabeth A Martin, Karen Brown, Margaret Gaskell, et al.
Psychiatric Services (Washington, D.C.)|January 30, 2026
Social Determinants and Mental Health Care Utilization Among Individuals at Clinical High Risk for PsychosisEmily Petti, Miranda A Bridgwater, Madeline E Snyder, et al.
Regulatory Toxicology and Pharmacology : RTP|August 7, 2021
Calculating qualified non-mutagenic impurity levels: Harmonization of approachesJessica C Graham, Mark W Powley, Erika Udovic, et al.
Critical Reviews in Toxicology|June 15, 2022
Framework for sensitization assessment of extractables and leachables in pharmaceuticalsPatricia Parris, Geraldine Whelan, Anders Burild, et al.
Schizophrenia Research|February 27, 2022
Internalized stigma mediates the relation between psychosis-risk symptoms and subjective quality of life in a help-seeking sampleLeeAnn Akouri-Shan, Joseph S DeLuca, Steven C Pitts, et al.
Frontiers in Psychiatry|March 30, 2023
Review of factors resulting in systemic biases in the screening, assessment, and treatment of individuals at clinical high-risk for psychosis in the United StatesMiranda A Bridgwater, Emily Petti, Maksim Giljen, et al.
Pageof 13